SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001640334-22-001763
Filing Date
2022-08-15
Accepted
2022-08-12 21:49:36
Documents
16
Period of Report
2022-08-12

Document Format Files

Seq Description Document Type Size
1 skyebioscienceincproxy.htm PREM14A 4934909
2 ex_filingfees.htm EX-FILING FEES 16397
3 image_0a.jpg GRAPHIC 29243
4 image_01a.jpg GRAPHIC 1013
5 image_02a.jpg GRAPHIC 35707
6 image_32a.jpg GRAPHIC 79
7 image_95a.jpg GRAPHIC 75
8 image_99.jpg GRAPHIC 75
9 image_103.jpg GRAPHIC 107
10 image_107a.jpg GRAPHIC 161
11 image1a.jpg GRAPHIC 11206
12 imagea.jpg GRAPHIC 165
13 picture1a.jpg GRAPHIC 4869
14 skyeproxycardproof3_2a.jpg GRAPHIC 182493
15 skyeproxycardproof3a.jpg GRAPHIC 119275
16 skye-xlogoxxblacka.jpg GRAPHIC 208624
  Complete submission text file 0001640334-22-001763.txt   5770298
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 000-55136 | Film No.: 221162025
SIC: 2834 Pharmaceutical Preparations